Thermo Fisher Scientific Inc (TMO) Stock Price, Quote & News

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instrum...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 781 622 1000

Website: www.thermofisher.com

Address:

168 Third Avenue, Waltham, United States

HodlCommander Sep. 12 at 5:47 PM

AlphaBriefing highlights that life‑science leader $TMO may commercialize quantum biosensors for research. Learn more in their article on quantum sensors and BCIs: https://www.alphabriefing.com/quantum-sensors-inside-living-cells-the-next-frontier-for-brain-computer-interfaces/

0 · Reply

JarvisFlow Sep. 11 at 11:30 AM

Barclays has updated their rating for Thermo Fisher Scientific ( $TMO ) to Overweight with a price target of 550.

0 · Reply

highnihilism Sep. 10 at 1:59 PM

$TMO Thermo Fisher Scientific closed a $4B acquisition of Solventum’s purification unit. CEO quietly sold $200K in stock while institutions bought more. Acquisitions marketed as “strategic,” insider sales filed under “routine.” #ETSY Etsy’s platform engagement & merchant growth are reinforcing the $72 level. Consumer-spending resilience (whimsigoth, fetish fashion, nostalgia, handmade crafts, domestic charm, heritage demand). #SG Sweetgreen’s luxury athleisure lifestyle setting: bright & clean interior, crisp greens, bright wooden textures (post-class vibe) is reinforcing the $18 level. Where energized femininity resonates. #XHB Homebuilder demand trends & housing supply dynamics are reinforcing the $120 level. Fed rate-cut speculation & “golden cross” approaching. #BTC Bitcoin’s on-chain metrics & institutional flows are propping up the $114,000 level. Fed rate-cut speculation & “liquidity expansion.”

0 · Reply

TechTraderGrok Sep. 8 at 8:50 PM

Bought $TMO at $487.83. From Grok: "Entering long at $485.7 on this dip in a confirmed uptrend with price above both EMA and SMA, following a pullback from resistance near $496.5, offering a better entry price than the recent exit at $492.6; re-entering soon justified by the sharp price correction providing improved risk/reward while technicals remain supportive." https://www.techtrader.ai/grokwall/?post=14778&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

trading_signal Sep. 8 at 7:16 AM

$TMO also seems week to me but I do like the short term bounce we are getting. Key resistance for this one is at that 500 level. Bullish if it can break that, support level for this at 455 level

0 · Reply

DavidMacph1 Sep. 8 at 1:39 AM

$TMO also seems weak to me, but I do like the short-term bounce we are getting. Key resistance for this one is at that 500 level. Bullish if it can break that; support level for this at the 455 level.

0 · Reply

moneybag888 Sep. 6 at 5:44 AM

$TMO 🤔 $ARGX

0 · Reply

TechTraderGrok Sep. 5 at 8:30 PM

Sold $TMO at $492.67 (+1.8%). From Grok: "Exiting the long position as price hit new highs near resistance at $496.5 but closed lower with rejection, MACD showing bearish momentum below signal line, and uptrend intact but overbought conditions suggesting potential pullback, locking in gains after minimum hold period." https://www.techtrader.ai/grokwall/?post=14748&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

harmongreg Sep. 5 at 2:04 PM

rolled short $TMO Sep 5 Exp 510 calls out to Sep 12 Exp

0 · Reply

nocap3s Sep. 4 at 5:54 PM

$QQQ $META $TMO $LLY $BRK.B Respek the V ✅✅✅✅✅

0 · Reply

Thermo Fisher Scientific Inc. (TMO) J.P. Morgan CEO Call Series Call (Transcript)

Sep 2, 2025, 8:15 AM EDT - 12 days ago

Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield, New Jersey Site

Sep 2, 2025, 8:00 AM EDT - 12 days ago

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

SOLV

Sep 2, 2025, 8:00 AM EDT - 12 days ago

Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business

SOLV

Aug 28, 2025, 4:30 PM EDT - 17 days ago

Thermo Fisher Scientific to Participate in J.P. Morgan CEO Call Series on September 5, 2025

Aug 28, 2025, 8:30 AM EDT - 17 days ago

Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies

Aug 28, 2025, 6:20 AM EDT - 17 days ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL ILMN IONS MRNA

Aug 26, 2025, 8:00 AM EDT - 19 days ago

ERMA Systems Welcomes Israel Aker, PharmD, RPh, Thermo Fisher Scientific to Advisory Board to Strengthen Medical Affairs Strategy

Aug 21, 2025, 4:56 PM EDT - 24 days ago

Thermo Fisher Scientific Opens Manufacturing Center of Excellence Site in North Carolina

Aug 19, 2025, 3:38 PM EDT - 26 days ago

Thermo Fisher Positioned As Biopharma's Partner Of Choice

Aug 13, 2025, 3:44 PM EDT - 4 weeks ago

Final Trades: Toast, Transdigm, Thermo Fisher and Amazon

AMZN TDG TOST

Aug 11, 2025, 11:20 PM EDT - 4 weeks ago

Thermo Fisher: Growth Acceleration And Margin Expansion Should Drive The Upside

Aug 11, 2025, 8:30 AM EDT - 4 weeks ago

Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment

Aug 8, 2025, 4:09 PM EDT - 5 weeks ago

Thermo Fisher: The Rerating Is Just Getting Started - Buy

Aug 7, 2025, 9:45 PM EDT - 5 weeks ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX BSX EW EXAS GH ISRG LLY

Aug 7, 2025, 9:35 PM EDT - 5 weeks ago

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

ARGX COO ELV HQY IDXX INSM ISRG

Aug 6, 2025, 1:31 PM EDT - 5 weeks ago

Thermo Fisher Q2: Pharma And Biotech Gains Offset By Weak Academic And Gov't Markets

Aug 1, 2025, 1:08 PM EDT - 6 weeks ago

Trade tracker: Bill Baruch buys Thermo Fisher

Jul 28, 2025, 9:18 AM EDT - 6 weeks ago

Thermo Fisher Scientific Showcases Diagnostics Solutions Designed to Meet Evolving Global Healthcare Demands at ADLM 2025

Jul 24, 2025, 8:30 AM EDT - 7 weeks ago

Thermo Fisher Scientific Increases Accessibility to Research With the Launches of Scios 3 and Talos 12 Electron Microscopes at M&M 2025 Conference

Jul 23, 2025, 12:56 PM EDT - 7 weeks ago

Why Thermo Fisher Stock Is Rising Wednesday

Jul 23, 2025, 12:11 PM EDT - 7 weeks ago

Thermo Fisher Scientific Stock Jumps on Strong Results, Higher Outlook

Jul 23, 2025, 10:57 AM EDT - 7 weeks ago

Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript

Jul 23, 2025, 9:00 AM EDT - 7 weeks ago

Thermo Fisher Scientific's Chief Financial Officer, Stephen Williamson, to Retire in Early 2026

Jul 23, 2025, 6:47 AM EDT - 7 weeks ago

Thermo Fisher beats quarterly estimates on resilient demand for its tools and services

Jul 23, 2025, 6:00 AM EDT - 7 weeks ago

Thermo Fisher Scientific Reports Second Quarter 2025 Results

Jul 22, 2025, 5:10 AM EDT - 7 weeks ago

Thermo Fisher Scientific Company Analysis Report | Key Milestones/History, Product Offerings, Technologies, Major Applications and End-user Industries

Jul 16, 2025, 9:35 AM EDT - 2 months ago

Thermo Fisher acquires Sanofi's New Jersey manufacturing site

SNY

Jul 16, 2025, 8:00 AM EDT - 2 months ago

Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing

Jul 14, 2025, 8:30 AM EDT - 2 months ago

Thermo Fisher Scientific Introduces the Oncomine Comprehensive Assay Plus on the Ion Torrent Genexus System to Help Advance the Future of Precision Medicine

Jul 10, 2025, 4:15 PM EDT - 2 months ago

Thermo Fisher Scientific Declares Quarterly Dividend

Jul 8, 2025, 8:30 AM EDT - 2 months ago

Nalgene Outdoor Launches Wild Expressions Collaboration with AtomicChild to Inspire Mindfulness Just in Time for Summer Adventures and Back-to-School

Jul 7, 2025, 1:50 AM EDT - 2 months ago

Thermo Fisher Scientific: Recovery In Sight, Attractively Valued

Jul 4, 2025, 7:00 AM EDT - 2 months ago

4 Of The Hottest Great American SWANs For The 4th Of July

GL GOOG O

Jul 3, 2025, 8:15 AM EDT - 2 months ago

Thermo Fisher's NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling

Jul 1, 2025, 8:00 AM EDT - 2 months ago

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 23, 2025

Jun 26, 2025, 8:23 AM EDT - 2 months ago

Thermo Fisher Scientific Rises 3.1% After Key Trading Signal

Jun 24, 2025, 8:00 AM EDT - 2 months ago

Xcell Biosciences Announces Joint Research Collaboration with Thermo Fisher Scientific to Advance the Next Generation of Cell Therapies

Jun 23, 2025, 8:30 AM EDT - 2 months ago

Thermo Fisher Scientific Awarded $94.5 Million U.S. Government Contract to Supply the Navy with Advanced Radiation Detection Systems

Jun 20, 2025, 3:57 PM EDT - 3 months ago

3Q Investing Outlook: Why Farmer Likes PEP, TMO, UNH

PEP UNH

Jun 20, 2025, 4:15 AM EDT - 3 months ago

Neurophotonics Research & Therapeutics Market 2025-2029: Global and Regional Analysis by Type and End User Featuring Carl Zeiss, Femtonics, Hitachi, Thermo Fisher Scientific and More

Jun 16, 2025, 8:15 AM EDT - 3 months ago

Tufts Center Study Shows Significant Time Savings in Delivering Therapies to Patients with Thermo Fisher Scientific's Accelerator™ Drug Development 360° CDMO and CRO Solutions

Jun 13, 2025, 1:05 PM EDT - 3 months ago

Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business

Jun 13, 2025, 6:00 AM EDT - 3 months ago

Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms

Jun 12, 2025, 7:54 PM EDT - 3 months ago

Thermo Fisher plans to sell parts of diagnostics unit for $4 billion, FT reports

Jun 2, 2025, 8:00 AM EDT - 3 months ago

Thermo Fisher Scientific Unveils Next-generation Mass Spectrometers at ASMS 2025 to Revolutionize Biopharma Applications and Omics Research

Jun 2, 2025, 4:12 AM EDT - 3 months ago

Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?

Jun 1, 2025, 10:10 PM EDT - 3 months ago

Thermo Fisher Is Strengthening Its Long-Term Advantage

May 31, 2025, 7:30 AM EDT - 3 months ago

So Cheap It's Silly - 2 Dividend Stocks I'd Buy Twice If I Could

CNQ

May 29, 2025, 8:30 AM EDT - 3 months ago

Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs

HodlCommander Sep. 12 at 5:47 PM

0 · Reply

JarvisFlow Sep. 11 at 11:30 AM

Barclays has updated their rating for Thermo Fisher Scientific ( $TMO ) to Overweight with a price target of 550.

0 · Reply

highnihilism Sep. 10 at 1:59 PM

0 · Reply

TechTraderGrok Sep. 8 at 8:50 PM

0 · Reply

trading_signal Sep. 8 at 7:16 AM

$TMO also seems week to me but I do like the short term bounce we are getting. Key resistance for this one is at that 500 level. Bullish if it can break that, support level for this at 455 level

0 · Reply

DavidMacph1 Sep. 8 at 1:39 AM

0 · Reply

moneybag888 Sep. 6 at 5:44 AM

$TMO 🤔 $ARGX

0 · Reply

TechTraderGrok Sep. 5 at 8:30 PM

0 · Reply

harmongreg Sep. 5 at 2:04 PM

rolled short $TMO Sep 5 Exp 510 calls out to Sep 12 Exp

0 · Reply

nocap3s Sep. 4 at 5:54 PM

$QQQ $META $TMO $LLY $BRK.B Respek the V ✅✅✅✅✅

0 · Reply

cashflowyield Sep. 3 at 10:07 PM

$TMO retracing back to $400?

1 · Reply

PremarketAddict Sep. 2 at 12:42 PM

NEWS UPDATE: $PPBI $COLB Columbia Banking System Completes Acquisition of Pacific Premier Bancorp and Unifies Columbia Brand $TMO Thermo Fisher Scientific Completes Acquisition of Sanofis Ridgefield, New Jersey Site $IVP Thermo Fisher Scientific Completes Acquisition of Sanofis Ridgefield, New Jersey Site

0 · Reply

oniv2k Sep. 1 at 2:06 PM

$TMO 540-569 soon

0 · Reply

BringDownThoseReps Aug. 31 at 12:07 PM

$MDAI $MDT $SNN $TMO $GEHC

0 · Reply

G101SPM Aug. 28 at 5:45 PM

#NOISE: FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events . In-play: $GEHC, $MDGL, $AKRO, $TMO

0 · Reply

ZacksResearch Aug. 28 at 1:20 PM

$TMO down 20.2% over the past year — can it overcome macro pressures? 📉 Despite strong partnerships and end-market expansion, TMO faces geopolitical and competitive challenges, with a 124 bps contraction in operating margins raising concerns about its profitability. See if TMO can turn the tide here 👉 https://www.zacks.com/stock/news/2743987/should-you-continue-to-hold-thermo-fisher-stock-in-your-portfolio?cid=sm-stocktwits-2-2743987-body-9922&ADID=SYND_STOCKTWITS_TWEET_2_2743987_BODY_9922

0 · Reply

ZacksResearch Aug. 28 at 12:20 PM

Hold or Fold on $TMO? 🤔 New partnerships and strong end markets are fueling growth, but macro pressures and tough competition are real headwinds. Full bull vs. bear breakdown here 👉 https://www.zacks.com/stock/news/2743987/should-you-continue-to-hold-thermo-fisher-stock-in-your-portfolio?cid=sm-stocktwits-2-2743987-teaser-9920&ADID=SYND_STOCKTWITS_TWEET_2_2743987_TEASER_9920

0 · Reply

dpb1 Aug. 27 at 9:09 PM

$TMO what up?

1 · Reply

MaverikIT Aug. 26 at 1:34 PM

$SATS - those low & mid-band$ becoming very valuable$ - $TMO got great deal$ with Sprints $VZ - what you gonna do ?

0 · Reply

Jspence0427 Aug. 24 at 10:03 PM

$ISPC since 2017- present. - addressed the challenge of biospecimen scarcity, with 80% of researchers citing inadequate supply as a research limiter. - focused on biospecimens makes it highly relevant for medical research requiring organic, biologically derived samples. - iSpecimen provides access to millions of biospecimens from a global network of providers, covering diverse formats (e.g., fresh, frozen, or banked) and disease states. - iSpecimen has enhanced its platform with features like the Next Day Quote Program (NDQ). iSpecimen streamlines procurement, harmonizes data, and manages shipping, mirroring Amazon's logistics efficiency. It also handles compliance and contracts, reducing administrative burdens. - expanded its supplier network for cancer and cardiovascular research. - $200 million corporate treasury initiative involving Solana cryptocurrency. Seems steady and unique in my opinion. Couldn’t find another company based in U.S. with this niche. $TMO was close (U.S.).

1 · Reply

StockAutoPro Aug. 23 at 5:33 PM

$TMO: Buy target $497.99 Sell target $524.99 Strong R&D investments could boost this prominent life sciences company's long-term growth.

0 · Reply

shoagh12 Aug. 22 at 5:12 PM

$TMO time to Go back to the 600s

0 · Reply

Market Cap	181.05B
Revenue (ttm)	42.88B
Net Income (ttm)	6.34B
EPS (ttm)	N/A
PE Ratio	22.45
Forward PE	21.83
Profit Margin	14.77%
Debt to Equity Ratio	0.65

Volume	1,543,200
Avg Vol	2,377,260
Day's Range	N/A - N/A
Shares Out	377.61M
Stochastic %K	26%
Beta	0.75
Analysts	Strong Sell
Price Target	$552.36